Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) ...

BioSymetrics is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to ...

Let’s break down the top five reasons your cancer treatment is disrupting your sleep and what you can do about it!

The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today ...

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...